Today there are many scales to choose from. Psychiatrists familiar with these tools will be better able to interpret clinical trial results and to employ them in assessing patients’ clinical progress. Here we review the most commonly used depression rating scales, as well as some newer web-based tools.
Read More
You greet a new patient who complains of difficulty concentrating at work and is unable to “keep up” since making partner at a law firm or becoming an attending physician at a hospital. Is this an authentic case of a high-functioning person with undiagnosed adult ADHD, a subtle request for performance enhancement, or something altogether different?
Read More
PTDS is one of the greatest mental health concerns in veterans, but there is a stigma, among veterans, on issues related to seeking mental health services. Dr. Kean discusses effective screening methods, current findings and treatment options.
Read More
Do you know what other medications your depressed patients are taking? You should. If they’re taking non-steroidal anti-inflammatory drugs (NSAIDs), they may be less likely to respond to SSRIs.
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
